These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21554238)
1. [Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD]. Demir T; Günen H; Polatlı M; Yıldırım N Tuberk Toraks; 2011; 59(1):89-100. PubMed ID: 21554238 [TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013. Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome. Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033 [TBL] [Abstract][Full Text] [Related]
6. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
7. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
9. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study. Bogart M; Stanford RH; Reinsch T; Hull M; Buikema A; Hulbert E Respir Med; 2018 Sep; 142():73-80. PubMed ID: 30170806 [TBL] [Abstract][Full Text] [Related]
11. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of early medication use for COPD: a population-based cohort study. Falk J; Dik N; Bugden S Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449 [TBL] [Abstract][Full Text] [Related]
14. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659 [TBL] [Abstract][Full Text] [Related]
15. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]
16. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm. Wilkie M; Finch S; Schembri S COPD; 2015; 12(5):582-90. PubMed ID: 25774769 [TBL] [Abstract][Full Text] [Related]
17. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis. Cave AC; Hurst MM Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815 [TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods. Kwak MS; Kim E; Jang EJ; Kim HJ; Lee CH Int J Chron Obstruct Pulmon Dis; 2015; 10():2365-76. PubMed ID: 26604734 [TBL] [Abstract][Full Text] [Related]
19. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study. Ivanov Y; Nikolaev I; Nemeth I Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539 [TBL] [Abstract][Full Text] [Related]